Ketorolac (Toradol): a marketing phenomenon.
Ariano
R E
RE
Zelenitsky
S A
SA
D000329:Advertising; D000700:Analgesics / Q000191:economics / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D020911:Ketorolac Tromethamine; D010818:Practice Patterns, Physicians'; D011358:Product Surveillance, Postmarketing; D014046:Tolmetin / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D014325:Tromethamine / Q000191:economics / Q000627:therapeutic use*
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D014325:Tromethamine; D020911:Ketorolac Tromethamine; D014046:Tolmetin